Targeted anti-cancer therapy in the elderly.

作者: Wilson Gonsalves , Apar Kishor Ganti

DOI: 10.1016/J.CRITREVONC.2010.06.001

关键词:

摘要: Cancer is a disease of the elderly with majority new diagnoses and deaths from cancer occurring in persons greater than 65 years age. A major goal therapy, preservation functional independence quality life. The advent targeted therapies has raised hope that older patients could be treated as effectively younger without added toxicities. However, caution must exercised while addressing use these population only after taking into consideration risks, benefits prognosis on an individual basis. This article reviews current literature efficacy, cost-effectiveness toxicity currently approved agents population.

参考文章(103)
Snezana K Bjelogrlic, Sinisa Radulovic, Sunitinib, sorafenib and mTOR inhibitors in renal cancer. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. ,(2007)
M. E. Gore, C. Porta, S. Oudard, G. Bjarnason, D. Castellano, C. Szczylik, P. N. Mainwaring, P. Schöffski, B. I. Rini, R. M. Bukowski, Sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of toxicity in an expanded access trial with subpopulation analysis Journal of Clinical Oncology. ,vol. 25, pp. 5010- 5010 ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.5010
Jay R. Harris, Marc E. Lippman, Umberto Veronesi, Walter Willett, Breast cancer: (Second of three parts) The New England Journal of Medicine. ,vol. 327, pp. 390- 398 ,(1992) , 10.1056/NEJM199208063270606
Rebecca A. Miksad, Lowell Schnipper, Michael Goldstein, Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value Journal of Clinical Oncology. ,vol. 25, pp. 4506- 4507 ,(2007) , 10.1200/JCO.2007.13.0401
Ming-Sound Tsao, Akira Sakurada, Jean-Claude Cutz, Chang-Qi Zhu, Suzanne Kamel-Reid, Jeremy Squire, Ian Lorimer, Tong Zhang, Ni Liu, Manijeh Daneshmand, Paula Marrano, Gilda da Cunha Santos, Alain Lagarde, Frank Richardson, Lesley Seymour, Marlo Whitehead, Keyue Ding, Joseph Pater, Frances A. Shepherd, Erlotinib in lung cancer - molecular and clinical predictors of outcome. The New England Journal of Medicine. ,vol. 353, pp. 133- 144 ,(2005) , 10.1056/NEJMOA050736
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme De Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F Greten, Peter R Galle, Jean-François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, Marius Moscovici, Dimitris Voliotis, Jordi Bruix, None, Sorafenib in Advanced Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 359, pp. 378- 390 ,(2008) , 10.1056/NEJMOA0708857
Alessandro Vitale, Michael L. Volk, Davide Pastorelli, Sara Lonardi, Fabio Farinati, Patrizia Burra, Paolo Angeli, Umberto Cillo, Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology. ,vol. 51, pp. 165- 173 ,(2010) , 10.1002/HEP.23260
Heinz Ludwig, Roman Hajek, Elena Tóthová, Johannes Drach, Zdenek Adam, Boris Labar, Miklós Egyed, Ivan Spicka, Heinz Gisslinger, Richard Greil, Ingrid Kuhn, Niklas Zojer, Axel Hinke, Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma. Blood. ,vol. 113, pp. 3435- 3442 ,(2009) , 10.1182/BLOOD-2008-07-169565
Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang, Jianming Xu, Yan Sun, Houjie Liang, Jiwei Liu, Jiejun Wang, Won Young Tak, Hongming Pan, Karin Burock, Jessie Zou, Dimitris Voliotis, Zhongzhen Guan, None, Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncology. ,vol. 10, pp. 25- 34 ,(2009) , 10.1016/S1470-2045(08)70285-7
Bernard Escudier, Tim Eisen, Walter M Stadler, Cezary Szczylik, Stéphane Oudard, Michael Siebels, Sylvie Negrier, Christine Chevreau, Ewa Solska, Apurva A Desai, Frédéric Rolland, Tomasz Demkow, Thomas E Hutson, Martin Gore, Scott Freeman, Brian Schwartz, Minghua Shan, Ronit Simantov, Ronald M Bukowski, None, Sorafenib in advanced clear-cell renal-cell carcinoma. The New England Journal of Medicine. ,vol. 356, pp. 125- 134 ,(2007) , 10.1056/NEJMOA060655